You can read the abstract of this article at LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial PubMed (nih.gov)
Author correction: Tau binding protein CAPON induces tau aggregation and neurodegeneration
There are however, many patients who do not suffer from any of the above historical side effects but rather have dermatologic mild responses like slight swelling or redness around the injection site
The Noom Engagement Report: New Data Shows that the GLP-1 Patients Who Use Noom the Most Also Lose the Most Weight and Stay On Medication Program Longest Most-engaged members lost 25.2% more weight at week 40 and persisted 2.2x longer on medication program than least-engaged members using the Noom app, demonstrating the benefits of combining GLP-1 medication with Noom's GLP-1 Companion behavior-change program PRINCETON, N.J., Feb
Hair Growth: Emerging research indicates potential benefits for hair follicle health and stimulation of hair growth, making it an ingredient in some hair care products
doi: 10.2337/dc19-0749 58 O'NeilPMBirkenfeldALMcGowanBMosenzonOPedersenSDWhartonSet al